LAMEA Healthcare Bioconvergence Market Size, Share & Industry Trends Analysis Report By Application (Drug Discovery, Precision Medicine, Regenerative Medicine, Diagnostic & Biological Sensors, Bioelectronics, Nanorobotics for Drug Delivery, Engineered Living Materials, and Optogenetics), By Country and Growth Forecast, 2022 - 2028

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Healthcare Bioconvergence Market, by Application
1.4.2 LAMEA Healthcare Bioconvergence Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Healthcare Bioconvergence Market by Application
3.1 LAMEA Drug Discovery Market by Country
3.2 LAMEA Precision Medicine Market by Country
3.3 LAMEA Regenerative Medicine Market by Country
3.4 LAMEA Diagnostic & Biological Sensors Market by Country
3.5 LAMEA Bioelectronics Market by Country
3.6 LAMEA Nanorobotics for Drug Delivery Market by Country
3.7 LAMEA Engineered Living Materials Market by Country
3.8 LAMEA Optogenetics Market by Country

Chapter 4. LAMEA Healthcare Bioconvergence Market by Country
4.1 Brazil Healthcare Bioconvergence Market
4.1.1 Brazil Healthcare Bioconvergence Market by Application
4.2 Argentina Healthcare Bioconvergence Market
4.2.1 Argentina Healthcare Bioconvergence Market by Application
4.3 UAE Healthcare Bioconvergence Market
4.3.1 UAE Healthcare Bioconvergence Market by Application
4.4 Saudi Arabia Healthcare Bioconvergence Market
4.4.1 Saudi Arabia Healthcare Bioconvergence Market by Application
4.5 South Africa Healthcare Bioconvergence Market
4.5.1 South Africa Healthcare Bioconvergence Market by Application
4.6 Nigeria Healthcare Bioconvergence Market
4.6.1 Nigeria Healthcare Bioconvergence Market by Application
4.7 Rest of LAMEA Healthcare Bioconvergence Market
4.7.1 Rest of LAMEA Healthcare Bioconvergence Market by Application

Chapter 5. Company Profiles
5.1 BiomX, Inc.
5.1.1 Company Overview
5.1.2 Research & Development Expenses
5.2 Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expenses
5.3 BICO Group AB (publ)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental and Regional Analysis
5.3.4 Recent strategies and developments:
5.3.4.1 Partnerships, Collaborations, and Agreements:
5.3.4.2 Acquisition and Mergers:
5.4 Ginkgo Bioworks Holdings, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Research & Development Expenses
5.4.4 Recent strategies and developments:
5.4.4.1 Partnerships, Collaborations, and Agreements:
5.5 Singota Solutions
5.5.1 Company Overview
5.6 Anima Biotech Inc.
5.6.1 Company Overview
5.7 Setpoint Medical Corporation
5.7.1 Company Overview